Investment Firm
Overview
Arcellx is a clinical-stage biotechnology company that provides patients with immune cell therapies.
Nov 15, 2023
Post Ipo Equity
Highlights
Location
Social
Investor Lead
Participant Investors
1
Investor Name |
---|
Kite Pharma |
Arcellx raised $200000000 on 2023-11-15 in Post-IPO Equity
Arcellx is a clinical-stage biotechnology company that provides patients with immune cell therapies.
Company Funding History
7
Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
---|---|---|---|---|
Mar 10, 2022 | Post-IPO Equity - Arcellx | - | 10.0M | |
Jun 15, 2022 | Post-IPO Equity - Arcellx | - | 112.0M | |
Dec 09, 2022 | Post-IPO Equity - Arcellx | 1 | - | 100.0M |
Nov 15, 2023 | Post-IPO Equity - Arcellx | 1 | - | 200.0M |
Recent Activity
There is no recent news or activity for this profile.